The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer models-Reference-Cited by-同舟云学术

The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer models

Published:2014-10-01 Issue:1 Volume:5 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Wang Wei,Qin Jiang-Jiang,Voruganti Sukesh,Srivenugopal Kalkunte S.,Nag Subhasree,Patil Shivaputra,Sharma Horrick,Wang Ming-Hai,Wang Hui,Buolamwini John K,Zhang Ruiwen

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms6086.pdf

Reference58 articles.

1. Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. CA Cancer J. Clin. 64, 9–29 (2014).

2. DeSantis, C., Ma, J., Bryan, L. & Jemal, A. Breast cancer statistics, 2013. CA Cancer J. Clin. 64, 52–62 (2014).

3. Lorusso, G. & Ruegg, C. New insights into the mechanisms of organ-specific breast cancer metastasis. Semin. Cancer Biol. 22, 226–233 (2012).

4. Oakman, C., Santarpia, L. & Di Leo, A. Breast cancer assessment tools and optimizing adjuvant therapy. Nat. Rev. Clin. Oncol. 7, 725–732 (2010).

5. Marmot, M. G. et al. The benefits and harms of breast cancer screening: an independent review. Br. J. Cancer 108, 2205–2240 (2010).

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ARID1A safeguards the canalization of the cell fate decision during osteoclastogenesis;Nature Communications;2024-07-17

2. Phase Separation Enhanced PROTAC for Highly Efficient Protein Degradation;Biomacromolecules;2024-06-03

3. MDM2 stabilization of Notch intracellular domain upon DNA damage plays a major role in non-small cell lung carcinoma response to platinum chemotherapy;2024-05-01

4. Current perspectives and trend of computer-aided drug design: a review and bibliometric analysis;International Journal of Surgery;2024-03-19

5. MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future;Pharmacological Reviews;2024-03-15